Live feed
Filing
SC 13D/A
SC 13D/A0001193125-17-038117·Ocera Therapeutics, Inc.
Schedule 13D ownership disclosure
TRANZYME INC
Security class unavailable · CUSIP: 89413J102
Event date: 2017-02-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-038117
- Form type
- SC 13D/A
- Filer
- Ocera Therapeutics, Inc.
- CIK
- CIK 1274644
- Filed
- Feb 10, 2017
- Reporting period
- Feb 08, 2017
- Description
- Schedule 13D beneficial ownership